IQVIA艾昆纬：2024亚太地区罕见病研究报告-市场格局概述（英文版）

lobally, the focus on rare diseases has grown considerably over the last few years. Even in the APAC region, rare disease area is gaining momentum owing to the pronounced disease burden and unique challenges that patients face. Countries in the region have varying degrees of maturity regarding rare disease management, with developed markets having more comprehensive ecosystems for care delivery and middle-income countries (e.g., India) still in the midst of establishing comprehensive policies